Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Turner Syndrome Market Grown from 2024 to 2025?
In recent years, the market size for Turner syndrome has seen robust growth. The market is projected to expand from $2.36 billion in 2024 to $2.55 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.0%. The previous growth period was driven by heightened awareness of women’s health, increased funding for healthcare, expansion of the healthcare sector, greater attentiveness and early detection of Turner syndrome, and initiatives to increase public awareness.
What Growth Rate Is Anticipated for the Turner Syndrome Market in the Coming Years?
Expectations are high for significant expansion in the Turner syndrome market in the upcoming years, with estimations suggesting that it will reach a value of $3.42 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.7%. This expected growth during the forecast period may be driven by an increase in instances of structural abnormalities of the X chromosome, the prevalent use of estrogen replacement therapy, and growing application of chromosomal microarray analysis (CMA) for disease diagnostics. Further factors include a growing female population and intensifying R&D activities. The forecast period is also likely to see trends such as the uptake of emerging technologies, the launching of new products, strides in growth hormone therapy, a rise in demand for hormonal treatments, and the emergence of innovative therapies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21310&type=smp
Who Are the Leading Companies in the Turner Syndrome Market?
Major companies operating in the turner syndrome market are Pfizer Inc., Sanofi SA, AstraZeneca Plc, Abbott Laboratories, Novartis AG, LG Chem Ltd., Eli Lilly and Company, Novo Nordisk, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Genentech Inc., Ipsen Pharma, Ferring Pharmaceutical, BioMarin Pharmaceutical Inc., United Imaging Healthcare Co. Ltd., Daewoong Pharmaceutical Co. Ltd., OPKO Health Inc., Hanmi Pharmaceutical Co. Ltd., Dong-A ST Co. Ltd., GeneScience Pharmaceuticals Co. Ltd., Ascendis Pharma, AnkeBio Co. Ltd., Biopartners Inc., Kexing Biopharm Co. Ltd.
What Are the Key Drivers of the Turner Syndrome Market?
The growth of the turner syndrome market is projected to be fuelled by the rising female populace. This term refers to the cumulative quantity of females residing either in a defined region or worldwide. Factors contributing to this increase include enhanced healthcare, a longer life expectancy, and demographic changes. Support for the female populace is primarily through turner syndrome treatments, providing growth hormone therapy to augment stature, offering estrogen replacement to initiate puberty and maintain bone health, and comprehensive medical care to manage linked disorders, significantly boosting physical development, reproductive health, and overall welfare. For example, the Census Bureau, an American government agency, estimated in March 2024 that the female population of the United States was around 168 million in July 2022. Besides this, it was noted that females aged 85 and above were approximately 1.9 million more. Moreover, according to a report by CEIC Data, a British financial service firm, issued in December 2022, the quantity of females aged 15-64 increased to 2,951,856 in 2022, up from 2,940,645 in 2021. Consequently, the growth of the turner syndrome market is driven by the escalating female populace.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21310&type=smp
What Are the Key Market Segments in the Turner Syndrome Industry?
The turner syndrome market covered in this report is segmented –
1) By Type: Classical Turner Syndrome, Mosaic Turner syndrome
2) By Therapy Type: Growth Hormone Therapy, Estrogen And Progesteron, Replacement Therapy, Other Therapy Types
3) By Drug Type: Norditropin, Oxandrolone, Humatrope, Somatropin, Oxandrin, Genotropin, Nutropin, Zomacton
4) By End-User: Hospitals, Homecare, Specialty Clinics, Surgical Centres, Other End-Users
Subsegments:
1) By Classical Turner Syndrome: Complete Monosomy X, X Chromosome Deletion
2) By Mosaic Turner Syndrome: Mosaicism With 45,X/46,XX Karyotype, Mosaicism With 45,X/46,XY Karyotype
What Are the Latest Trends in the Turner Syndrome Market?
Major firms in the Turner syndrome market are concentrating their efforts on clinical trials to create groundbreaking products like pediatric growth hormone medications. These are meant to efficiently boost growth, enhance height outcomes, and foster overall development in children suffering from growth hormone deficiencies or growth-related disorders. These medications, either synthetic or recombinant hormones, are designed to trigger growth and development in children with growth hormone deficiency (GHD) or other medical conditions that influence height and growth. For example, in December 2024, Ascendis Pharma A/S, a biopharmaceutical firm based in Denmark, reported promising results from the Phase 2 New InsiGHTS trial of TransCon hGH (lonapegsomatropin) which was tested on children with Turner syndrome. The trial comprised 49 Turner syndrome affected prepubertal children within the age of 1-10 years. TransCon hGH showed improved growth across all three initial dose groups, equaling the performance of daily somatropin. These trial results pave the way for potential market growth of TransCon hGH in the Turner syndrome sector, with efficacy and safety profile comparable to daily treatment.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/turner-syndrome-global-market-report
What Are the Key Regional Markets in the Turner Syndrome Industry?
North America was the largest region in the turner syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the turner syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21310
This Report Delivers Insight On:
1. How big is the turner syndrome market, and how is it changing globally?
2. Who are the major companies in the turner syndrome market, and how are they performing?
3. What are the key opportunities and risks in the turner syndrome market right now?
4. Which products or customer segments are growing the most in the turner syndrome market?
5. What factors are helping or slowing down the growth of the turner syndrome market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
